title: [Chronic inflammation and AA amyloidosis].
abstract: Systemic AA amyloidosis is a severe complication of chronic inflammatory diseases. Renal involvement is the predominant organ manifestation. Patients who are at risk for developing AA amyloidosis should be screened for microalbuminuria. The goal of therapy is an effective control of the acute phase reaction. A well controlled blood pressure and nephroprotective treatment contribute to the maintenance of renal function. In case of progressive amyloidosis dialysis is required. Renal transplantation can be performed if the underlying disease is well controlled.
authors.affiliation: Universitätsklinikum Heidelberg, Medizinische Klinik 5, Sektion Rheumatologie und Amyloidosezentrum, Heidelberg.
authors.forename: N
authors.initials: N
authors.lastname: Blank
authors.forename: S O
authors.initials: SO
authors.lastname: Schönland
mesh_terms: D000686:Amyloidosis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D016030:Kidney Transplantation; D009404:Nephrotic Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006435:Renal Dialysis; D000685:Serum Amyloid A Protein / Q000032:analysis*
chemical_list: D000685:Serum Amyloid A Protein